Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

Percentage of participants recruited into PrEP care at initiation

Percentage of participants retained in PrEP care at the end of 1 year

Number of participants who adhered to target injection windows period by completing injection appointments versus the number of participants who missed their target injection window period by not completing injection appointments

age in years at study initiation

Percentage of people who were assigned female at birth or assigned male at birth

Percentage of people with gender identity of male, female, trans male, trans female, genderqueer or gender nonconforming, different identity, prefer not to answer at initiation of study.

Percentage of people who identify as American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Pacific Islander, White, other, or prefer not to answer) race at initiation of study.

Percentage of people who identify hispanic or latino, not hispanic or latino, prefer not to answer) ethnicity at initiation of study.

Percentage of people with Medicaid, Medicare, commercial insurance, or uninsured throughout the study.

Percentage of people who have a steady place to live, a place to live today but worried about losing it in the future, or do not have a steady place to live at initiation of study.

Percentage of people who have a primary care provider relationship at initiation of study.

Percentage of people with more than 1 sexual partner at initiation of study.

Percentage of people who have one or more sexual partner who is HIV positive at initiation.

Percentage of people who have inconsistent condom use during sex.

Percentage of people who use injection drugs

Percentage of people who use HIV post exposure prophylaxis (PEP) in the last 12 months at initiation

Percentage of people who use HIV post exposure prophylaxis (PEP) in the last 12 months at initiation

A baseline questionnaire will be used at initiation to collect background characteristics to determine percentage of people of a race, ethnicity, gender identity, sex assigned at birth, marital status, education level, employment status, annual income, and living situation.

A baseline questionnaire will be used at initiation to collection information on percentage of people who engage in sex, has sex with and partner who is living with HIV, has sex without a condom, been diagnosed with an STI in the last 6 months, have used HIV post-exposure prophylaxis in the lat 12 months,

A 27 item questionnaire that will be given at baseline that explores the reason a person would like to be on an injection for PrEP, reasons for not being able to make injection appointments, and rating their feelings around judgement for being on an injection.

A 7 item questionnaire will be given at every follow up appointment that explores the reason someone wants to stay on an injectable for PrEP, how comfortable they feel being on the injection, reasons for not being able to make injection appointments, and rating their feelings around judgement for being on an injection.

A 2 item questionnaire will be given a discontinuation that explores why a person discontinues long acting cabotegravir and what their HIV prevention strategy will be moving forward.

A 5 point questionnaire that explores a pharmacists reasons for providing long acting injectable cabotegravir for PrEP, reasons for being able to or not being able to provide the service.

A 6 item questionnaire that explores the reasons a pharmacist is able to or not able to provide the service

number of chlamydia, syphilis, and gonorrhea infections detected during study

Number of HIV seroconversions detected during the study, reason for patient discontinuation, pharmacist provider and patient perspectives on barriers and facilitators.

A 2 item questionnaire will be given a discontinuation that explores why a person discontinues long acting cabotegravir and what their HIV prevention strategy will be moving forward.

A 6 item questionnaire that explores the reasons a pharmacist cannot provide the service

A 6 item questionnaire that explores the reasons a pharmacist can provide the service

A 7 item questionnaire will be given at every follow up appointment that explores the reason someone can use the service.

A 7 item questionnaire will be given at every follow up appointment that explores the reason someone cannot use the service.